Burleson & Company, LLC Boston Scientific Corp Transaction History
Burleson & Company, LLC
- $384 Million
- Q4 2022
A detailed history of Burleson & Company, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Burleson & Company, LLC holds 44 shares of BSX stock, worth $4,302. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44
Previous 44
-0.0%
Holding current value
$4,302
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BSX
# of Institutions
1,918Shares Held
1.26BCall Options Held
9.73MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA137MShares$13.4 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY126MShares$12.4 Billion0.22% of portfolio
-
State Street Corp Boston, MA65.2MShares$6.37 Billion0.27% of portfolio
-
Primecap Management CO Pasadena, CA34.7MShares$3.39 Billion3.04% of portfolio
-
Bank Of America Corp Charlotte, NC33.8MShares$3.31 Billion0.27% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $140B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...